Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Safety and Efficacy of Leucine-Restricted Diet Combined With Chemotherapy and Immunotherapy in Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating a leucine-restricted diet in combination with chemotherapy and immunotherapy for advanced gastric cancer, …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: ICG (Indocyanine Green) Imaging Fluorescence Technology in Surgical Treatment of Advanced Gastric Cancer
A clinical trial is recruiting to evaluate indocyanine green (ICG) fluorescence imaging technology in the surgical treatment of advanced gas…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Combination of TATE and PD-1 Inhibitor in Liver Cancer [Phase 2]
Phase 2 clinical trial updating on the combination of TATE and a PD-1 inhibitor for hepatocellular carcinoma and gastric cancer, currently r…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating first-line gastric cancer treatment with a PD-1/TGF-β bispecific agent SHR-1701 in combination with SHR255…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Laparoscopic Staging for Stage III Gastric Cancer [NA]
Ongoing clinical trial evaluating laparoscopic staging for stage III gastric cancer; the study is currently enrolling by invitation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer [Phase 1]
Phase 1 study evaluating paclitaxel for gastric cancer and gastroesophageal junction adenocarcinoma; the trial includes metastatic/stage IV …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for Enzelkitug as a single agent and in combination with a checkpoint inhibitor in adults with locally advance…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study evaluating oral MOMA-341 in adults with advanced or metastatic solid tumors, including endometrial, colorectal, and gastric ca…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer [Phase 2]
A Phase 2 clinical trial evaluating nivolumab and ipilimumab in combination with chemoradiation for resectable gastric cancer and gastroesop…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer [Phase 2]
A Phase 2 trial evaluating chemotherapy with or without radiation or surgery for oligometastatic gastric or esophageal cancer; the study is …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy [Phase 2, Phase 3]
A Phase 2/3 trial comparing ramucirumab plus FOLFIRI versus ramucirumab plus paclitaxel in patients with advanced or metastatic gastric/EGJ …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-positive, HER2-negative, Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaUnresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 1, Phase 2]
A Phase Ib/II clinical trial evaluating ATG-022 in combination with pembrolizumab, with or without chemotherapy, for CLDN18.2-positive, HER2…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer [Phase 1]
This Clinical Trial Update describes a Phase 1 study evaluating the addition of BAY 1895344 to standard chemotherapy (cisplatin or cisplatin…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 [Phase 3]
Phase 3 trial evaluating Sonesitatug Vedotin with Capecitabine, with or without Rilvegostomig, in advanced or metastatic Claudin18.2-express…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Costs of Opportunistic Upper Gastrointestinal Endoscopy and the Economic Burden of Gastric Cancer Management
This clinical trial update analyzes the costs of opportunistic upper gastrointestinal endoscopy and the economic burden of managing gastric …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer
Clinical trial update on an AI-assisted approach to guide decision-making for reoperation in patients experiencing postoperative bleeding af…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute's Cancer Moonshot Biobank update outlines the trial's status and scope, indicating the study is active but not rec…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Vanguard Study: Testing a New Way to Screen for Cancer [NA]
The Vanguard Study is a National Cancer Institute–sponsored cancer screening trial that is currently recruiting to evaluate a new screening …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers [Phase 1]
Clinical trial update indicating Janssen's investigational asset JNJ-89402638 is in Phase 1 testing for metastatic colorectal and gastric ca…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan [Phase 1]
Phase 1 trial evaluating the safety, adverse events, and pharmacokinetics of Azirkitug alone or in combination with Budigalimab, Bevacizumab…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations [Phase 2]
This clinical trial update describes a Phase 2 study evaluating talazoparib in patients with advanced cancers and DNA repair variations, and…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Phase 1/1b Study of IAM1363 in HER2 Cancers [Phase 1]
IAM1363 is being studied in a Phase 1/1b trial for HER2-related cancers, and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer [Phase 2, Phase 3]
Pfizer is enrolling patients in a Phase 2/Phase 3 study testing PF-08634404 with chemotherapy for untreated advanced or metastatic gastric c…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy [Phase 1]
This Phase 1 trial update describes evaluating ropidoxuridine as a radiosensitizer in patients with advanced gastrointestinal cancers underg…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer [Phase 3]
This Phase 3 trial is evaluating rilvegostomig in combination with a fluoropyrimidine and trastuzumab deruxtecan as first-line therapy for H…